Oncology & Cancer
Breakthrough drug shows early promise for multiple myeloma
A small clinical trial has shown that a new drug has promise for targeting tumours in patients with an aggressive type of blood cancer.
Oct 8, 2018
0
26
British Journal of Haematology
The British Journal of Haematology publishes original research papers in clinical, laboratory and experimental haematology. The Journal also features annotations, reviews, short reports, images in haematology and Letters to the Editor.
- Publisher
- Wiley
- Website
- http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2141/issues
- Impact factor
- 4.941 (2011)
Oncology & Cancer
New test predicts survival in blood cancer patients
(Medical Xpress)—Scientists have developed a test which accurately predicts the prognosis for patients with the most common form of leukaemia.
Jul 9, 2014
0
0
Oncology & Cancer
New drugs are improving survival times for patients with aggressive type of blood cancer, study finds
Survival times for a highly aggressive type of blood cancer have nearly doubled over the last decade due to the introduction of new targeted drugs, a Yorkshire study has shown.
Jun 25, 2018
0
83
Oncology & Cancer
Newborns with Down's syndrome to receive leukaemia test under new guidelines
New genetic testing has been developed at the University of Oxford to detect early signs of a potentially fatal condition that can also develop into full blown leukaemia in children with Down's syndrome.
Jun 20, 2018
0
100
Medications
Scientists prove low cost arthritis drug can effectively treat blood cancer sufferers
A simple arthritis drug could be an effective, low cost solution to treat patients with blood cancers such as polycythemia vera (PV) and essential thrombocythemia (ET), a breakthrough study by the University of Sheffield ...
Sep 16, 2019
0
162
Diseases, Conditions, Syndromes
Blood clotting a significant cause of death in patients with COVID-19
A study led by clinician scientists at RCSI University of Medicine and Health Sciences has found that Irish patients admitted to hospital with severe COVID-19 infection are experiencing abnormal blood clotting that contributes ...
Apr 30, 2020
0
5
Medical research
'Magic bullet' found in fight against leukemia
Researchers have made a huge leap forward in finding a targeted therapy for acute myeloid leukemia.
Nov 10, 2021
0
116
Oncology & Cancer
Study finds 5-year relative survival rate of 59.6 percent in lower-risk myelodysplastic syndromes
About 40 percent of patients with lower-risk myelodysplastic syndromes (LR-MDS) die of MDS within five years, according to a study published online Nov. 6 in the British Journal of Haematology.
Nov 23, 2022
0
2
Oncology & Cancer
Impact of COVID-19 infection in blood cancer patients
One of the first studies to investigate the outcome of COVID-19 infection in patients with blood cancer has been conducted by clinical researchers from Queen Mary University of London and Barts Health NHS Trust.
Jun 2, 2020
0
4
Medical research
Faulty arginine metabolism contributes to cardiopulmonary dysfunction in thalassemia
A research study of patients with thalassemia found that low bioavailability of the amino acid arginine may contribute to pulmonary hypertension – increased blood pressure in the pulmonary artery, pulmonary vein or pulmonary ...
Jul 10, 2015
0
68
